7575 Stock Overview
Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Amed Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$61.30 |
| 52 Week High | NT$86.00 |
| 52 Week Low | NT$56.56 |
| Beta | 0 |
| 1 Month Change | -4.67% |
| 3 Month Change | -8.37% |
| 1 Year Change | 3.97% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.13% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 7575 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -5.4% | -2.6% | -2.6% |
| 1Y | 4.0% | -0.2% | 25.9% |
Return vs Industry: 7575 exceeded the TW Medical Equipment industry which returned -0.2% over the past year.
Return vs Market: 7575 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 7575 volatility | |
|---|---|
| 7575 Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.4% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 7575 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7575's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | n/a | www.amed.com.tw |
Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name.
Amed Co., Ltd. Fundamentals Summary
| 7575 fundamental statistics | |
|---|---|
| Market cap | NT$1.84b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 7575 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7575 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 7575 perform over the long term?
See historical performance and comparison